8-K
filed May 21, 2026, 4:10 PM ET
ticker ANAB
CIK 0001370053
other
confidence high
sentiment neutral
materiality 0.15
AnaptysBio changes fiscal year-end from Dec 31 to June 30, effective July 1, 2026
ANAPTYSBIO, INC
- Board approved fiscal year change from December 31 to June 30, effective July 1, 2026.
- Company will file a transition report on Form 10-KT for the six-month period Jan 1, 2026 to June 30, 2026.
- Quarterly reports will follow new fiscal year, beginning with the quarter ending September 30, 2026.
- Change is effective for the company's next fiscal year starting July 1, 2026.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-234419
- form_type
- 8-K
- ticker
- ANAB
- cik
- 0001370053
- company_name
- ANAPTYSBIO, INC
- filed_at
- 2026-05-21T20:10:15+00:00
- discovered_at
- 2026-05-21T20:11:00.271716+00:00
- generated_at
- 2026-05-21T22:15:37.353553+00:00
- sec_items
- ["5.03"]
- event_type
- other
- sentiment
- neutral
- materiality_score
- 0.15
- calibrated_materiality_score
- 0.15
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-234419
- json_url
- https://secwatch.observer/filing/0001193125-26-234419.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-234419.md
- text_url
- https://secwatch.observer/filing/0001193125-26-234419.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1370053/000119312526234419/0001193125-26-234419-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1370053/000119312526234419/anab-20260518.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
OPLN
OPENLANE eliminates Series A Convertible Preferred Stock from charter
OPENLANE, Inc.
May 29, 2026, 1:57 PM ET
other
Items 5.03, 9.01
same SEC item: 5.03
same event type: other
similar materiality
Filing page
SEC filing
CAL
Caleres reduces board size from 11 to 10; shareholders re-elect all directors and approve compensation plan
CALERES INC
May 28, 2026, 5:22 PM ET
other
Items 5.03, 5.07, 9.01
same SEC item: 5.03
same event type: other
similar materiality
Filing page
SEC filing
SLE
Super League Enterprise cancels Series AA Preferred Stock designation
Super League Enterprise, Inc.
May 27, 2026, 4:31 PM ET
other
Items 3.03, 5.03, 9.01
same SEC item: 5.03
same event type: other
similar materiality
Filing page
SEC filing
PGNY
Progyny shareholders approve elimination of supermajority voting requirements
Progyny, Inc.
May 27, 2026, 9:13 AM ET
other
Items 5.03, 5.07, 9.01
same SEC item: 5.03
same event type: other
similar materiality
Filing page
SEC filing
CDW
CDW shareholders approve written consent; independent board chair proposal defeated
CDW Corp
May 26, 2026, 4:03 PM ET
other
Items 5.03, 5.07, 9.01
same SEC item: 5.03
same event type: other
similar materiality
Filing page
SEC filing
TCRX
TScan Therapeutics stockholders approve doubling authorized shares to 600M and elect directors
TScan Therapeutics, Inc.
May 22, 2026, 4:05 PM ET
other
Items 5.03, 5.07, 9.01
same SEC item: 5.03
same event type: other
similar materiality
Filing page
SEC filing
Digimarc Parent, Inc.
Digimarc Parent renames to Digimarc Corporation; effective May 21, 2026
Digimarc Parent, Inc.
May 21, 2026, 1:41 PM ET
other
Items 5.03, 9.01
same SEC item: 5.03
same event type: other
similar materiality
Filing page
SEC filing
XXI
Twenty One Capital amends charter and bylaws to remove SoftBank references; elects Texas code
Twenty One Capital, Inc.
May 20, 2026, 9:54 PM ET
other
Items 5.03, 5.07, 9.01
same SEC item: 5.03
same event type: other
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.